These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26247254)

  • 1. [Prevalence of congenital abnormalities identified in fetuses with 13, 18 and 21 chromosomal trisomy].
    Emer CS; Duque JA; Müller AL; Gus R; Sanseverino MT; da Silva AA; Magalhães JA
    Rev Bras Ginecol Obstet; 2015 Jul; 37(7):333-8. PubMed ID: 26247254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal diagnosis of trisomy 18 syndrome with sonogram index scoring system].
    Peng R; Xie HN; Zhang Y; Luo YM; Li LJ; Zhu YX; Lin MF
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):845-9. PubMed ID: 22333235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosome abnormalities and congenital heart diseases: a retrospective on 49 cases].
    Zhang L; Zhang XH; Ren MH; Song GN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):312-5, 323. PubMed ID: 20506661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between prenatal atrioventricular septal defects and chromosomal abnormalities.
    Morlando M; Bhide A; Familiari A; Khalil A; Morales-Roselló J; Papageorghiou AT; Carvalho JS
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():31-35. PubMed ID: 27888703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine death in singleton pregnancies with trisomy 21, 18, 13 and monosomy X.
    Goulart VV; Liao AW; Carvalho MH; Brizot Mde L; Francisco RP; Zugaib M
    Rev Assoc Med Bras (1992); 2016 Apr; 62(2):162-70. PubMed ID: 27167547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.
    Zhu Y; Lu S; Bian X; Wang H; Zhu B; Wang H; Xu Z; Xu L; Yan W; Zeng Y; Chen Z; Tang S; Shen G; Miao Z
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):379-84. PubMed ID: 27343319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study.
    Tennstedt C; Chaoui R; Körner H; Dietel M
    Heart; 1999 Jul; 82(1):34-9. PubMed ID: 10377306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.
    Zhou Q; Pan L; Chen S; Chen F; Hwang R; Yang X; Wang W; Jiang J; Xu J; Huang H; Xu C
    Prenat Diagn; 2014 Nov; 34(11):1061-5. PubMed ID: 24899146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study.
    Nishiyama M; Sekizawa A; Ogawa K; Sawai H; Nakamura H; Samura O; Suzumori N; Nakayama S; Yamada T; Ogawa M; Katagiri Y; Murotsuki J; Okamoto Y; Namba A; Hamanoue H; Ogawa M; Miura K; Izumi S; Kamei Y; Sago H
    Prenat Diagn; 2016 Dec; 36(12):1121-1126. PubMed ID: 27760457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France].
    Benachi A; Letourneau A; Kleinfinger P; Senat MV; Gautier E; Favre R; Bidat L; Houfflin-Debarge V; Querol V; Bouyer J; Costa JM;
    J Gynecol Obstet Biol Reprod (Paris); 2016 Jun; 45(6):633-40. PubMed ID: 26518155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound diagnosis of fetal abnormalities and cytogenetic evaluation.
    van Zalen-Sprock MM; van Vugt JM; Karsdorp VH; Maas R; van Geijn HP
    Prenat Diagn; 1991 Aug; 11(8):655-60. PubMed ID: 1837358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective cohort of trisomy 18 (Edwards syndrome) in southern Brazil.
    Denardin D; Savaris FE; da Cunha AC; Betat Rda S; Telles JA; Targa LV; Weiss A; Zen PR; Rosa RF
    Sao Paulo Med J; 2015; 133(4):320-5. PubMed ID: 25388684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.